Delivery Order SPE2DR25D2009-SPE2DR26FJ3E9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,416.41. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. The work is to be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $48,840.25 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $3,877.63 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on August 27, 2025, with completion scheduled for August 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,138.46 on October 22, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Eliquis 5 mg tablets in a 60-count quantity, with a firm fixed price ceiling value of $2,273.15 and a completion date of November 6, 2025. This non-set-aside, competitively awarded contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency awarded a $22,765.02 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-unit quantity) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside, competitively awarded transaction. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $43,474.14 by the Defense Logistics Agency on November 5, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by November 6, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $12,110.70, with an ultimate completion date of June 2, 2025. This non-set-aside competitive award represents a single delivery order issued against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at approximately $60.3K to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3E9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,184.62 to supply Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award was issued on November 14, 2025, with an ultimate completion date of November 17, 2025, with performance to take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal medical supplier that provides comprehensive pharmaceutical and medical supply support to military and veteran healthcare systems. The company's SPE2DX prime contract vehicle serves as a global pharmaceutical support mechanism enabling delivery of a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Eliquis—an anticoagulant medication—is consistent with AmerisourceBergen's extensive portfolio of federal pharmaceutical deliveries ranging from routine commodity supplies to specialized therapeutic products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 11/14/25 |